NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/01/2026
Voltar para busca
Dado oficial do USPTO
AVITI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
13/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
11/06/2021
Data de registro
13/01/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/01/2026
Última transação
13/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
14/03/2023
Primeiro uso no comércio
14/03/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
San Diego, CA
Examinador
LE, KHANH M
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Element Biosciences, Inc.
Representantes
Samantha C. Markley LOZA & LOZA, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for scientific research usefor diagnostic scientific usefor clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical diagnostic laboratory purposes
Classe 5
Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for diagnostic medical use and for clinical medical use
Classe 9
Computer systemscomputer hardwaredownloadable and recorded computer software and associated downloadable data files for collectingstoringanalyzing and reporting biological informationfor sample tracking and managing projectslaboratory workflow and dataall the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collectionmanagementanalysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific usenucleic acid sequencersimaging devices and analyzers
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
13/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22/12/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22/12/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/12/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
15/12/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
15/12/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/12/2025
IUAF
USE AMENDMENT FILED
24/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2025
DRRR
DIVISIONAL REQUEST RECEIVED
12/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/06/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/06/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX4G
SOU EXTENSION 4 GRANTED
07/12/2024
EXT4
SOU EXTENSION 4 FILED
07/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/06/2024
EX3G
SOU EXTENSION 3 GRANTED
10/06/2024
EXT3
SOU EXTENSION 3 FILED
10/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2023
EX2G
SOU EXTENSION 2 GRANTED
30/11/2023
EXT2
SOU EXTENSION 2 FILED
30/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
30/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2023
EX1G
SOU EXTENSION 1 GRANTED
06/06/2023
EXT1
SOU EXTENSION 1 FILED
06/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/10/2022
PUBO
PUBLISHED FOR OPPOSITION
18/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2022
GNRT
NON-FINAL ACTION E-MAILED
07/03/2022
CNRT
NON-FINAL ACTION WRITTEN
07/03/2022
DOCK
ASSIGNED TO EXAMINER
28/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2021
NWAP
NEW APPLICATION ENTERED
15/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVITI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.